52.8 F
Los Angeles
Sunday, December 22, 2024

CHA Hollywood Hospital receives ‘A’ rating in National Hospital Safety Grades

- Advertisement -

CHA Hollywood Presbyterian Medical Center, the only Korean-owned general hospital in the U.S. operated by CHA Bio Group, has received an “A” rating in the Fall 2024 Hospital Safety Grades from Leapfrog, a nonprofit consumer watchdog organization.

Leapfrog evaluated over 3,000 general hospitals nationwide based on more than 30 indicators, including errors, accidents, injuries, infections, and preventative systems. Fewer than 30% of hospitals nationwide earned an “A” rating in this assessment, with 128 hospitals in California, including CHA Hollywood Hospital, achieving this distinction.

Jamie Yoo, CEO of CHA Hollywood Hospital, commented on the achievement, stating, “This recognition is a testament to CHA Hollywood Hospital’s unwavering commitment to patient safety and the tireless efforts of our medical staff. We will continue striving to create an environment that ensures the utmost comfort and safety for our patients.”

 

CHA Hollywood Presbyterian Medical Center receives ‘A’ rating in the Fall 2024 Hospital Safety Grades from Leapfrog.

 

Leapfrog’s hospital safety assessment is the only program exclusively focused on preventable medical errors. The program is peer-reviewed, conducted transparently, and made freely accessible to the public. Ratings are updated twice annually, in the fall and spring. Detailed ratings and safety tips for patients are available at hospitalsafetygrade.org.

Founded in 1924, CHA Hollywood Hospital has been serving the health needs of Hollywood and neighboring communities for 100 years. The facility offers 434 total beds, including 89 nursing beds, and employs over 550 physicians and specialized medical professionals providing comprehensive care.

The hospital is part of CHA Health Systems, which operates 91 hospitals and clinics across seven countries, 30 research institutes, 14 educational institutions, and 31 bio, pharmaceutical, healthcare companies. As a key member of the CHA Bio Group, the hospital also contributes to stem cell research, education, and biotechnology innovation globally.

BY YOUNGNAM KIM [kim.youngnam@koreadaily.com]